Vir Biotechnology Inc. (VIR) Announces CFO Departure

On April 15, 2024, Sung Lee, Executive Vice President and Chief Financial Officer of Vir Biotechnology Inc. (NASDAQ: VIR), informed the Company that he will be stepping down from his role, effective May 3, 2024, to pursue another career opportunity. The Company has initiated a search for his successor. Mr. Lee’s resignation was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

You May Also Be Interested In

• Synaptics CFO resigns amid pending ON Semiconductor merger
• Arbutus plans $230M share repurchase via Dutch auction tender offer
• Synergy CHC gets Nasdaq notice over delayed quarterly filing